| Medical and Health Sciences | Lifetime | 17 | US 9 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 5 | US 3 | 100.00 |
| Surgery | Lifetime | 8 | US 3 | 99.99 |
| Cardiology and Cardiovascular Medicine | Lifetime | 6 | US 4 | 99.99 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 62 | US 34 | 99.80 |
| Epidemiology | Lifetime | 392 | US 207 | 99.50 |
| Pulmonary and Respiratory Medicine | Lifetime | 373 | US 205 | 99.53 |
| Internal Medicine | Lifetime | 46 | US 13 | 99.09 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 455 | US 263 | 98.88 |
| Nutrition and Dietetics | Lifetime | 669 | US 272 | 96.95 |
| Emergency Medicine | Lifetime | 829 | US 448 | 90.32 |
| Nephrology | Lifetime | 908 | US 403 | 84.10 |
| Biochemistry | Lifetime | 930 | US 411 | 77.85 |
| Medical Biochemistry | Lifetime | 721 | US 207 | 32.48 |
| Surgery | 2021-2025 | 6 | US 2 | 99.97 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 6 | US 4 | 99.98 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 18 | US 12 | 99.84 |
| Nutrition and Dietetics | 2021-2025 | 32 | US 4 | 99.15 |
| Epidemiology | 2021-2025 | 157 | US 49 | 99.00 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 120 | US 39 | 97.91 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 369 | US 118 | 96.36 |
| Molecular Biology | 2021-2025 | 785 | US 218 | 95.67 |
| Econometrics and Quantitative Economics | 2021-2025 | 766 | US 207 | 95.16 |
| Rheumatology | 2021-2025 | 212 | US 62 | 94.08 |
| Biochemistry | 2021-2025 | 53 | US 10 | 91.47 |
| Medical Physiology | 2021-2025 | 602 | US 220 | 90.73 |
| Statistics and Probability | 2021-2025 | 252 | US 99 | 82.50 |
| Clinical Neurology | 2021-2025 | 481 | US 184 | 82.04 |
| Emergency Medicine | 2021-2025 | 299 | US 133 | 76.89 |
| Clinical Pharmacology | 2021-2025 | 497 | US 144 | 72.56 |
| Immunology | 2021-2025 | 969 | US 365 | 57.00 |
| Cancer Research | 2021-2025 | 484 | US 199 | 52.90 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 1 | US 1 | 99.99 |
| Acute Myocardial Infarction Research | Lifetime | 3 | US 3 | 99.99 |
| Peripheral Artery Disease Management | Lifetime | 3 | US 3 | 99.90 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 7 | US 3 | 99.94 |
| Coronary Interventions and Diagnostics | Lifetime | 10 | US 7 | 99.97 |
| Diabetes Treatment and Management | Lifetime | 10 | US 5 | 99.91 |
| Lipoproteins and Cardiovascular Health | Lifetime | 9 | US 6 | 99.94 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 21 | US 8 | 99.92 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 31 | US 14 | 99.83 |
| Cardiac Imaging and Diagnostics | Lifetime | 73 | US 46 | 99.85 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 118 | US 57 | 99.64 |
| Blood Pressure and Hypertension Studies | Lifetime | 66 | US 32 | 99.68 |
| Cardiovascular Function and Risk Factors | Lifetime | 119 | US 79 | 99.75 |
| Heart Failure Treatment and Management | Lifetime | 55 | US 35 | 99.77 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 144 | US 72 | 99.50 |
| Acute Ischemic Stroke Management | Lifetime | 135 | US 59 | 99.53 |
| COVID-19 and healthcare impacts | Lifetime | 106 | US 39 | 97.87 |
| Fatty Acid Research and Health | Lifetime | 89 | US 34 | 98.95 |
| Cardiovascular Health and Disease Prevention | Lifetime | 131 | US 65 | 99.20 |
| Cardiac Health and Mental Health | Lifetime | 91 | US 53 | 99.02 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 140 | US 67 | 99.41 |
| Inflammatory mediators and NSAID effects | Lifetime | 121 | US 63 | 99.03 |
| Pharmacology and Obesity Treatment | Lifetime | 56 | US 29 | 99.13 |
| Cardiac Valve Diseases and Treatments | Lifetime | 315 | US 168 | 99.33 |
| Cardiovascular Issues in Pregnancy | Lifetime | 125 | US 57 | 98.67 |
| Diet and metabolism studies | Lifetime | 636 | US 278 | 98.88 |
| Heart Rate Variability and Autonomic Control | Lifetime | 375 | US 173 | 98.63 |
| Cardiovascular Disease and Adiposity | Lifetime | 253 | US 132 | 98.60 |
| COVID-19 Clinical Research Studies | Lifetime | 700 | US 163 | 97.50 |
| Cardiac and Coronary Surgery Techniques | Lifetime | 180 | US 95 | 98.09 |
| Stroke Rehabilitation and Recovery | Lifetime | 452 | US 137 | 98.22 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 449 | US 209 | 98.23 |
| Bariatric Surgery and Outcomes | Lifetime | 224 | US 113 | 97.48 |
| Pancreatic function and diabetes | Lifetime | 831 | US 351 | 97.87 |
| Potassium and Related Disorders | Lifetime | 98 | US 61 | 97.88 |
| Pharmaceutical Economics and Policy | Lifetime | 208 | US 113 | 97.06 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 371 | US 160 | 97.46 |
| Cardiac Arrhythmias and Treatments | Lifetime | 974 | US 440 | 97.71 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 443 | US 234 | 97.30 |
| Metabolism, Diabetes, and Cancer | Lifetime | 697 | US 304 | 97.55 |
| Vascular Procedures and Complications | Lifetime | 361 | US 203 | 97.60 |
| Cardiac Structural Anomalies and Repair | Lifetime | 840 | US 480 | 97.78 |
| Lipid metabolism and disorders | Lifetime | 291 | US 117 | 96.68 |
| Cardiac pacing and defibrillation studies | Lifetime | 881 | US 441 | 97.53 |
| Medication Adherence and Compliance | Lifetime | 252 | US 156 | 96.39 |
| Diabetes Management and Research | Lifetime | 929 | US 381 | 97.15 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 984 | US 376 | 96.20 |
| Hemodynamic Monitoring and Therapy | Lifetime | 974 | US 401 | 95.44 |
| Cardiovascular Health and Risk Factors | Lifetime | 469 | US 260 | 94.27 |
| Healthcare cost, quality, practices | Lifetime | 540 | US 297 | 93.94 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 422 | US 199 | 92.74 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 859 | US 373 | 93.37 |
| Clinical practice guidelines implementation | Lifetime | 893 | US 230 | 92.21 |
| Inertial Sensor and Navigation | Lifetime | 834 | US 185 | 93.01 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 379 | US 152 | 93.26 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 850 | US 366 | 91.66 |
| Statistical Methods in Clinical Trials | Lifetime | 952 | US 497 | 91.42 |
| Synthesis of β-Lactam Compounds | Lifetime | 530 | US 115 | 87.74 |
| Sodium Intake and Health | Lifetime | 896 | US 357 | 88.79 |
| Sex and Gender in Healthcare | Lifetime | 582 | US 312 | 76.71 |
| Oropharyngeal Anatomy and Pathologies | Lifetime | 771 | US 188 | 71.69 |
| Aortic Thrombus and Embolism | Lifetime | 632 | US 238 | 69.18 |
| Heart rate and cardiovascular health | Lifetime | 720 | US 212 | 68.08 |
| Acute Myocardial Infarction Research | 2021-2025 | 1 | US 1 | 99.98 |
| Coronary Interventions and Diagnostics | 2021-2025 | 2 | US 2 | 99.92 |
| Fatty Acid Research and Health | 2021-2025 | 1 | US 1 | 99.86 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 4 | US 2 | 99.87 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 11 | US 5 | 99.82 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 7 | US 2 | 99.89 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 8 | US 3 | 99.80 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 2 | US 2 | 99.43 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 44 | US 13 | 99.44 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 51 | US 15 | 99.08 |
| Diabetes Treatment and Management | 2021-2025 | 33 | US 21 | 99.67 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 24 | US 12 | 98.35 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 69 | US 39 | 99.53 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 62 | US 29 | 99.10 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 102 | US 36 | 98.53 |
| Heart Failure Treatment and Management | 2021-2025 | 60 | US 30 | 99.43 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 79 | US 35 | 98.25 |
| Lipid metabolism and disorders | 2021-2025 | 16 | US 6 | 97.61 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 37 | US 18 | 97.47 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 64 | US 27 | 97.83 |
| Peripheral Artery Disease Management | 2021-2025 | 73 | US 40 | 97.15 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 238 | US 103 | 98.38 |
| Pancreatic function and diabetes | 2021-2025 | 121 | US 61 | 97.49 |
| Diabetes Management and Research | 2021-2025 | 199 | US 106 | 97.31 |
| Diet and metabolism studies | 2021-2025 | 378 | US 116 | 96.21 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 280 | US 135 | 96.65 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 340 | US 117 | 95.94 |
| Potassium and Related Disorders | 2021-2025 | 35 | US 17 | 97.07 |
| Viral Infections and Immunology Research | 2021-2025 | 200 | US 62 | 92.81 |
| Infective Endocarditis Diagnosis and Management | 2021-2025 | 412 | US 153 | 94.63 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 318 | US 53 | 95.16 |
| Influenza Virus Research Studies | 2021-2025 | 312 | US 127 | 93.16 |
| Pharmaceutical Economics and Policy | 2021-2025 | 127 | US 52 | 92.19 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 555 | US 196 | 94.04 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 146 | US 53 | 90.78 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 572 | US 116 | 92.56 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 290 | US 57 | 88.10 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 437 | US 122 | 88.82 |
| Hormonal Regulation and Hypertension | 2021-2025 | 354 | US 79 | 89.36 |
| Apelin-related biomedical research | 2021-2025 | 50 | US 10 | 84.08 |
| Statistical Methods in Clinical Trials | 2021-2025 | 220 | US 92 | 87.68 |
| Cardiac and Coronary Surgery Techniques | 2021-2025 | 245 | US 74 | 83.43 |
| Pharmacology and Obesity Treatment | 2021-2025 | 285 | US 129 | 80.49 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 208 | US 68 | 74.97 |
| Vascular Procedures and Complications | 2021-2025 | 938 | US 344 | 77.61 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 949 | US 422 | 75.77 |
| Fibroblast Growth Factor Research | 2021-2025 | 393 | US 121 | 72.50 |
| Healthcare cost, quality, practices | 2021-2025 | 785 | US 340 | 72.39 |
| Sodium Intake and Health | 2021-2025 | 525 | US 125 | 70.48 |
| Electrolyte and hormonal disorders | 2021-2025 | 584 | US 151 | 68.60 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 635 | US 228 | 68.10 |
| Meta-analysis and systematic reviews | 2021-2025 | 897 | US 179 | 69.79 |
| Kruppel-like factors research | 2021-2025 | 476 | US 105 | 63.38 |
| Natural Products and Biological Research | 2021-2025 | 213 | US 17 | 59.69 |
| Advanced Causal Inference Techniques | 2021-2025 | 796 | US 416 | 58.26 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 779 | US 145 | 54.36 |
| Sex and Gender in Healthcare | 2021-2025 | 506 | US 192 | 52.34 |